Inactive Instrument

MedX Health Corp. Share Price Toronto S.E.

Equities

MDX

CA5850901037

Advanced Medical Equipment & Technology

Financials

Sales 2022 5L 4L 3.12Cr Sales 2023 5L 3L 2.79Cr Capitalization 1.57Cr 1.15Cr 96Cr
Net income 2022 -50L -36.51L -31Cr Net income 2023 -40L -29.21L -24Cr EV / Sales 2022 22.1 x
Net Debt 2022 48.55L 35.46L 30Cr Net Debt 2023 57.06L 41.67L 35Cr EV / Sales 2023 47 x
P/E ratio 2022
-1.25 x
P/E ratio 2023
-2.58 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 93.77%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 25/23/25
Director of Finance/CFO - 29/22/29
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 84 19/01/19
Chairman - 19/01/19
Chief Executive Officer - 25/23/25
More insiders
MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.
More about the company